[O3] Oral Session 3"Cancer 1"

[O3-2] Combination Therapy of HSV-1 based Oncolytic Virotherapy with STING activator 2'3'-cGAMP Synergistically Amplifies Systemic Anti-Tumor Immunity

^○Patricia Angela Alvero Sibal^1,2, Shigeru Matsumura¹, Toru Ichinose¹, Itzel Villalobos Bustos¹, Daishi Morimoto^1,2, Ibrahim Ragab Eissa^1,2,3, Mohamed Abdelmoneim^1,2,4, Mona Al Hussein Mostafa Aboalela^1,2,5, Nobuaki Mukoyama⁶, Maki Tanaka⁷, Yoshinori Naoe¹, Hideki Kasuya¹ (1.Cancer Immune Therapy Research Center, International Medical Education, Nagoya University, Graduate School of Medicine, 2.Department of Surgery II, Nagoya University, Graduate School of Medicine, 3.Sci., Tanta Univ., Egypt, 4.Microbiol., Vet. Med., Zagazig Univ., Egypt, 5.Med. Microbiol. and Immun., Zagazig Univ., Egypt, 6.Otol. Grad. Sch. Med., Nagoya Univ., 7.Takara Bio Inc.)